MASI - Masimo Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Masimo Corporation

52 Discovery
Irvine, CA 92618
United States
949-297-7000
http://www.masimo.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees1,500

Key Executives

NameTitlePayExercisedYear Born
Mr. Joseph E. KianiFounder, CEO & Chairman3.06M56.47M1965
Mr. Micah YoungExec. VP of Fin. & CFO680.74kN/A1979
Mr. Bilal MuhsinExec. VP of Marketing & Regulatory Affairs and COO826.39k2.91M1981
Dr. Steven J. BarkerChairman of Scientific Advisory Board, Chief Science Officer & Director171.73kN/A1945
Mr. Anand SampathExec. VP of Operations & Clinical Research796.62k2.69M1966
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. In addition, the company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, and handheld capnograph and capnometer devices; and O3 regional oximetry for tissue oxygen saturation measurement. Further, it provides Patient SafetyNet, a surveillance, remote monitoring, and clinician notification solution; MyView, a wireless presence-detection system; and connectivity devices. Additionally, the company offers Trace, a patient data visualization and reporting software that monitors Masimo Root and Radical-7. The company provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, long term care facilities, veterinarians and consumers. Masimo Corporation was founded in 1989 and is headquartered in Irvine, California.

Corporate Governance

Masimo Corporation’s ISS Governance QualityScore as of July 29, 2019 is 5. The pillar scores are Audit: 2; Board: 7; Shareholder Rights: 5; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.